91-105 of 401
Assessing the Role of Metabolic Factors in Psoriasis Management
AudioAbstractsAssessing the Role of Metabolic Factors in Psoriasis Management
Ryan Quigley
Recognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
DermConsultRecognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
Unmasking Psoriasis in Skin of Color: Clinical Clues and Care Strategies
DermConsultUnmasking Psoriasis in Skin of Color: Clinical Clues and Care Strategies
Amy McMichael, MD
Pediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
On the Frontlines of PsoriasisPediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
Charles Turck, PharmD, BCPS, BCCCP
Amy Paller, MS, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsultTYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Rewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
FCDC Action CenterRewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
- advertisement
How Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
FCDC Action CenterHow Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
Improving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
FCDC Action CenterImproving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
Eric Ruderman, MD
Combination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
FCDC Action CenterCombination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
Beyond Plaques: Treatment Challenges and Strategies in Palmoplantar Psoriasis
On the Frontlines of PsoriasisBeyond Plaques: Treatment Challenges and Strategies in Palmoplantar Psoriasis
Gates B. Colbert, MD
Eingun James Song, MD, FAAD, Co-CMO
Understanding Sebopsoriasis: Navigating the Clinical Overlap of Dermatoses
DermConsultUnderstanding Sebopsoriasis: Navigating the Clinical Overlap of Dermatoses
Raj Chovatiya, MD, PhD, MSCI, FAAD
Building Trust in Psoriasis Care: Tools for Better Patient Conversations
On the Frontlines of PsoriasisBuilding Trust in Psoriasis Care: Tools for Better Patient Conversations
Ryan Quigley
Benjamin Ehst, MD, PhD
- advertisement
Guselkumab in Skin of Color: Results from a Randomized Phase 3b Psoriasis Trial
DermConsultGuselkumab in Skin of Color: Results from a Randomized Phase 3b Psoriasis Trial
Nail Psoriasis: Evaluating Quality-of-Life Measures and Treatment Gaps
On the Frontlines of PsoriasisNail Psoriasis: Evaluating Quality-of-Life Measures and Treatment Gaps
Charles Turck, PharmD, BCPS, BCCCP
Shari Lipner, MD
Understanding Wound Dressing Innovations: From Basics to Advanced Therapies
Clinician's RoundtableUnderstanding Wound Dressing Innovations: From Basics to Advanced Therapies
Geoffrey Gurtner, MD, FACS
